BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 34237406)

  • 1. Senescent cells in cancer therapy: why and how to remove them.
    Zhang JW; Zhang D; Yu BP
    Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescent Cells in Cancer Therapy: Friends or Foes?
    Wang B; Kohli J; Demaria M
    Trends Cancer; 2020 Oct; 6(10):838-857. PubMed ID: 32482536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence of Tumor Cells in Anticancer Therapy-Beneficial and Detrimental Effects.
    Piskorz WM; Cechowska-Pasko M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting normal and cancer senescent cells as a strategy of senotherapy.
    Sikora E; Bielak-Zmijewska A; Mosieniak G
    Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
    Lau L; David G
    Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
    [No Abstract]   [Full Text] [Related]  

  • 9. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
    Rossi M; Abdelmohsen K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine roles of cellular senescence in promoting tumourigenesis.
    Gonzalez-Meljem JM; Apps JR; Fraser HC; Martinez-Barbera JP
    Br J Cancer; 2018 May; 118(10):1283-1288. PubMed ID: 29670296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
    Niklander SE; Lambert DW; Hunter KD
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Jekyll and Hyde of Cellular Senescence in Cancer.
    Demirci D; Dayanc B; Mazi FA; Senturk S
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescent cells and their secretory phenotype as targets for cancer therapy.
    Velarde MC; Demaria M; Campisi J
    Interdiscip Top Gerontol; 2013; 38():17-27. PubMed ID: 23503512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of senescence on the tumour microenvironment and response to therapy.
    Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
    FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
    Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
    J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SASP: Tumor Suppressor or Promoter? Yes!
    Rao SG; Jackson JG
    Trends Cancer; 2016 Nov; 2(11):676-687. PubMed ID: 28741506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategies targeting cellular senescence for cancer and other diseases.
    Wang X; Fukumoto T; Noma KI
    J Biochem; 2024 Apr; 175(5):525-537. PubMed ID: 38366629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Link Between Senescence and Cell Fate: Senescence-Associated Secretory Phenotype and Its Effects on Stem Cell Fate Transition.
    Pan Y; Gu Z; Lyu Y; Yang Y; Chung M; Pan X; Cai S
    Rejuvenation Res; 2022 Aug; 25(4):160-172. PubMed ID: 35658548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ageing, cellular senescence and chronic kidney disease: experimental evidence.
    Tan H; Xu J; Liu Y
    Curr Opin Nephrol Hypertens; 2022 May; 31(3):235-243. PubMed ID: 35142744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.